Table III.

Clinical outcome, device oriented composite endpoint and major adverse cardiovascular events after 12 months observation in comparison between patients with no or mild and moderate or severe calcification of target vessel. Follow-up was available in 468 patients. Total MACE number is not equal to added components. Few events may occur in 1 patients

Parameter	No and mild calcification (n = 380)	Moderate and severe calcification (n = 86)	P-value
DOCE	6 (1.59%)	3 (3.49%)	0.3
MACE	10 (2.64%)	4 (4.65%)	0.3
Death	1 (0.26%)	1 (1.16%)	0.3
MI	5 (1.32%)	3 (3.49%)	0.2
TLR with urgent PCI	5 (1.32%)	2 (2.33%)	0.6
TVR with urgent CABG	0 (0%)	0 (0%)	–
Stent thrombosis	1 (0.26%)	1 (1.16%)	0.3
Stent restenosis	8 (2.11%)	2 (2.33%)	1.0

CABG – coronary artery bypass grafting, DOCE – device-oriented composite endpoint, MACE – major adverse cardiovascular event, MI – myocardial infarction, PCI – percutaneous coronary interventions, TLR – target lesion revascularisation, TVR – target vessel revascularisation.